Targeting RNA helicases in cancer: The translation trap

Marise R Heerma van Voss1, Paul J van Diest2, Venu Raman3

  • 1Department of Radiology and Radiological Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

Insights

Targeting cancer cell translation machinery, specifically DEAD/H box RNA helicases, offers a promising therapeutic strategy. Inhibiting these RNA helicases can disrupt tumor cell survival and protein synthesis for anti-cancer treatments.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Cancer cells depend on protein synthesis for survival and growth.
  • Translational control is a key regulatory mechanism in cancer.
  • DEAD/H box RNA helicases play significant roles in mRNA translation.

Purpose of the Study:

  • To review the mechanisms by which DEAD/H box proteins regulate oncogenic translation.
  • To explore the therapeutic potential of targeting these RNA helicases in cancer.

Main Methods:

  • Literature review of studies on DEAD/H box proteins in cancer.
  • Analysis of molecular mechanisms of translational control.
  • Discussion of therapeutic strategies targeting RNA helicases.

Main Results:

  • DEAD/H box proteins are crucial regulators of protein synthesis in cancer cells.
  • Specific DEAD/H box family members are implicated in promoting tumor cell survival.
  • Inhibition of these helicases presents a viable anti-cancer therapeutic approach.

Conclusions:

  • Targeting translational control via DEAD/H box RNA helicases is a promising cancer therapy.
  • Understanding these mechanisms can lead to novel anti-cancer drug development.

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K
DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
24.3K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.8K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
18.4K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K